News from NYU Langone Health
Animal-To-Human Organ Transplants Hit Long-Awaited Testing Milestone. (Scientific American)
(2/13) The FDA has approved the first clinical trial evaluating genetically modified pig kidney transplants in humans, with NYU Langone Health, where Towana Looney, who continues to do well nearly three months after receiving a pig kidney transplant, as one of the two study sites; the trial will initially involve six participants, potentially expanding to 50, and will assess safety and efficacy, focusing on patients ineligible or unlikely to receive human kidneys within five years, with Robert Montgomery, MD, PhD, the H. Leon Pachter, MD, Professor of Surgery; chair of the Department of Surgery; and director of the NYU Langone Transplant Institute, calling this approval “a very important milestone,” emphasizing the significance of a clinical trial as “the gold standard for assessing the safety and efficacy of a new drug or treatment.”
57 Health Systems On Forbes’ List Of Best Large Employers. (Becker's Hospital Review)
(2/13) Forbes’ annual list of America’s best large employers featured NYU Langone Health among 57 hospitals and health systems, with the rankings based on a survey of over 217,000 employees evaluating criteria such as pay, work environment, training, and advancement opportunities.
Adenomas Linked To Greater Risk Of Colorectal Cancer, All-Cause Mortality. (HCPLive)
(2/13) Research from the Minnesota Colon Cancer Control Study found that individuals with adenomas detected during colonoscopy, whether advanced or nonadvanced, face a higher risk of colorectal cancer (CRC) compared to those without adenomas, with advanced adenomas linked to increased CRC and all-cause mortality; Aasma Shaukat, MD, MPH, a gastroenterologist and Robert M. and Mary H. Glickman Professor of Medicine at NYU Grossman School of Medicine, and colleagues wrote, “Studies have reported the association of advanced adenomas with increased risk of CRC and CRC-related death over the following 5 to 15 years compared with having no advanced adenomas.”
Also reporting is (2/13).
Dr Sabari On Considerations For Conducting And Interpreting HER2 Testing In NSCLC. (OncLive)
(2/14) Joshua K. Sabari, MD, associate professor, Department of Medicine, NYU Grossman School of Medicine, and medical director, Thoracic Medical Oncology, NYU Langone Health’s Perlmutter Cancer Center, discusses the importance of detecting HER2 alterations in non–small cell lung cancer (NSCLC), saying that exon 20 insertions, particularly the YVMA variant, are the most frequent subtype, and while HER2 mutations are rare, their detection is crucial for targeted treatment.
Super Bowl Ad Features NYU Langone Health Orthopedic Surgeon. (Becker's Hospital Review)
(2/12) NYU Langone Health leveraged the large audience of the 59th Super Bowl with a significant advertisement featuring former New York Giants receiver Victor Cruz and orthopedic surgeon Dr. Joseph Zuckerman, the Walter A. L. Thompson Professor of Orthopedic Surgery and chair of the Department of Orthopedic Surgery, who said, “It’s all about them coming together for the common goal,” and emphasizing NYU Langone Health as the top academic medical center in the U.S. for quality and social safety, supported by 4,500 physicians and 50,000 employees.
Is Your Nasty Cold Actually Whooping Cough? Here’s How To Tell. (SELF Magazine)
(2/13) Jorge Mercado, MD, a clinical associate professor, pulmonologist and critical care medicine specialist at NYU Langone Hospital–Brooklyn, explained that whooping cough initially presents symptoms similar to a common cold, such as congestion and mild cough, but evolves into severe coughing fits that can cause difficulty breathing and exhaustion, lasting several weeks; he emphasized the importance of medical evaluation to distinguish whooping cough from other causes like postnasal drip or asthma, and advised that vaccinated individuals typically experience milder symptoms due to a faster immune response.
7 Things You Shouldn’t Clean With Dish Soap. (Consumer Reports)
(2/13) Jennifer Stein, MD, PhD, a dermatologist and professor in the Ronald O. Perelman Department of Dermatology at NYU Langone Health, advises using gentle cleansers without alcohol and avoiding scrubbing, particularly for individuals with eczema, while Michelle Wong, PhD, a cosmetic chemist, explains that dish soap, though based on similar surfactant ingredients as skin cleansers, is more cleansing and can strip skin, making it unsuitable for facial use and potentially damaging to hair due to the absence of conditioning ingredients found in modern shampoos.